SEC Info℠ | Home | Search | My Interests | Help | Sign In | Please Sign In | ||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 11/16/20 Sanara MedTech Inc. S-8 POS 11/16/20 2:60K Blueprint/FA |
Document/Exhibit Description Pages Size 1: S-8 POS Post-Effective Amendment of a Form S-8 HTML 31K Registration 2: EX-23.3 Consent of Malonebailey LLP HTML 6K
smti_s8 |
Texas
|
59-2219994
|
(State
or other jurisdiction of
incorporation or
organization)
|
(I.R.S.
Employer Identification No.)
|
|
|
1200
Summit Ave., Suite 414
Fort
Worth, Texas
(Address of
Principal Executive Offices)
|
76102
(Zip
Code)
|
Large accelerated
filer ☐
|
Accelerated
filer ☐
|
|
Smaller reporting
company ☑
|
Non-accelerated
filer ☑
|
Emerging growth
company ☐
|
Exhibit No.
|
|
Description of Document
|
|
|
|
|
Certificate of Formation of Sanara MedTech Inc. (incorporated by
reference to Exhibit 3.1 to the Registrant’s Registration
Statement on Form S-1 filed with the SEC on April 11,
2008).
|
|
|
Amendment to Certificate of Formation of Sanara MedTech Inc.
(incorporated by reference to Exhibit A to the Registrant’s
Information Statement filed with the SEC on May 13,
2008).
|
|
|
Amendment to Certificate of Formation of Sanara MedTech Inc. of the
Certificate of Designations of the Series F Convertible Preferred
Stock (incorporated by reference to Exhibit 4.1 to the
Registrant’s Current Report on Form 8-K, filed with the SEC
on March 21, 2019).
|
|
4.4*
|
|
Amendments to Certificate of Formation of Sanara MedTech Inc. (i)
to increase the authorized common stock (April 20, 2015) and (ii)
to recapitalize the authorized capital stock and implement a
reverse stock split (May 3, 2019).
|
|
Bylaws of Sanara MedTech Inc. (incorporated by reference to Exhibit
3.2 to the Registrant’s Registration Statement on Form S-1
filed with the SEC on April 11, 2008).
|
|
|
Sanara MedTech Inc. Restated 2014 Omnibus Long Term Incentive Plan
(incorporated by reference to Exhibit A to the Registrant’s
Definitive Proxy Statement on Schedule 14A filed with the SEC on
June 25, 2020).
|
|
5.1*
|
|
Opinion of Kelly Hart & Hallman LLP regarding legality of
issued shares of common stock.
|
23.1*
|
|
Consent of Kelly Hart & Hallman LLP.
|
23.2*
|
|
Consent of MaloneBailey LLP, independent registered public
accounting firm.
|
|
Consent
of MaloneBailey LLP, independent registered public accounting
firm.
|
|
|
Power
of Attorney (set forth on the signature page of the Registration
Statement on Form S-8 filed with the SEC on February 21,
2020).
|
|
SANARA
MEDTECH INC.
(Registrant)
|
|
|
|
|
|
|
Date: November 16,
2020
|
By:
|
/s/ J. Michael
Carmena
|
|
|
|
J. Michael
Carmena
|
|
|
|
Vice Chairman and
Principal Executive Officer
|
|
Signature
|
|
Title
|
|
Date
|
|
|
|
|
|
*
Ronald
T. Nixon
|
|
Executive Chairman of the Board
|
||
|
|
|
|
|
J.
Michael Carmena
|
|
Vice Chairman of the Board
(Principal Executive Officer)
|
|
|
|
|
|
|
|
/s/ Robert A.
DeSutter
Robert
A. DeSutter
|
|
Director
|
|
|
|
|
|
|
|
*
Ann
Beal Salamone
|
|
Director
|
|
|
|
|
|
|
|
*
James
W. Stuckert
|
|
Director
|
|
|
|
|
|
|
|
*
Kenneth
E. Thorpe
|
|
Director
|
|
|
|
|
|
|
|
|
Chief Financial Officer
(Principal Financial Officer and Principal Accounting
Officer)
|
|
This ‘S-8 POS’ Filing | Date | Other Filings | ||
---|---|---|---|---|
Filed on / Effective on: | 11/16/20 | |||
6/25/20 | DEF 14A | |||
2/21/20 | S-8 | |||
5/3/19 | ||||
3/21/19 | 8-K, DEF 14C | |||
4/20/15 | 8-K | |||
5/13/08 | 10-Q, DEF 14C | |||
4/11/08 | S-1 | |||
List all Filings |
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 6/25/20 Sanara MedTech Inc. DEF 14A 7/09/20 1:508K Blueprint/FA 2/21/20 Sanara MedTech Inc. S-8 2/21/20 5:764K Blueprint/FA 3/21/19 Sanara MedTech Inc. 8-K:1,2,3,5 3/21/19 3:3.8M Blueprint/FA 5/13/08 Sanara MedTech Inc. DEF 14C 5/09/08 1:55K Secs Transfer Corp./FA 4/11/08 Sanara MedTech Inc. S-1 6:272K Secs Transfer Corp./FA |